 |
D.C. Municipal Regulations (Last Updated: September 13, 2017) |
 |
Title 22. HEALTH |
|
SubTilte 22-B. PUBLIC HEALTH AND MEDICINE |
|
Chapter 22-B20. HOSPITALS |
Section 22-B2039. TESTING FOR SYNTHETIC CANNABINOID SURVEILLANCE
-
2039.1When a patient presents to a hospital with a reported or witnessed use of a synthetic cannabinoid and with signs and symptoms of overdose for which the treating clinician would otherwise order a standard urine drug screen, the hospital shall require the treating clinician to order a urine sample to be taken from the patient at or near the time of arrival at the emergency room.
2039.2When a patient presents to a hospital with a reported or witnessed use of a synthetic cannabinoid and with signs and symptoms of overdose for which the treating clinician would otherwise order a standard urine drug screen, the hospital may require the treating clinician to order a blood sample taken from the patient at or near the time of arrival at the emergency room.
2039.3The hospital shall label each urine sample or blood sample collected pursuant to Subsection 2039.1 or 2039.2 with the following patient identifying information:
(a)Name;
(b) Date of birth;
(c)Observed race and gender;
(d)Hospital name or hospital number; and
(e)Medical record number.
2039.4The hospital shall complete a Public Health Sample Submission Form created by the Office of the Chief Medical Officer for each urine sample or blood sample collected pursuant to Subsection 2039.1 or 2039.2.
2039.5The hospital shall keep the Public Health Sample Submission Form with the urine sample or blood sample collected pursuant to Subsection 2039.1 or 2039.2.
2039.6The hospital shall store each urine sample or blood sample arising from Subsection 2039.1 or 2039.2 according to protocols provided to the hospitals by the Department.
2039.7The hospital shall make each urine sample or blood sample collected pursuant to Subsection 2039.1 or 2039.2 available for pickup by an employee or authorized agent of the District who presents proper credentials or authorization from an appropriate District of Columbia official.
2039.8The hospital providing the patient’s urine sample or blood sample arising from Subsection 2039.1 or 2039.2 shall have no responsibility for testing the sample or for advising the patient of the results of the test of the sample that was provided to the District.
2039.9The hospital providing the patient’s urine sample or blood sample may request from the District the test results for a patient treated by the hospital.
2039.10Nothing in this rule restricts the ability of the hospital to conduct other testing on the patient.
2039.11These rules will expire on March 31, 2016.